Search Login Register
Sertoli-Leydig Cell Tumor
Summary
79
relevant articles (0 outcomes,
5 trials/studies)
found for this Disease
Description:
A sex cord-gonadal stromal tumor consists of LEYDIG CELLS; SERTOLI CELLS; and FIBROBLASTS in varying proportions and degree of differentiation. Most such tumors produce ANDROGENS in the Leydig cells, formerly known as androblastoma or arrhenoblastoma. Androblastomas occur in the TESTIS or the OVARY causing precocious masculinization in the males, and defeminization, or virilization (VIRILISM) in the females. In some cases, the Sertoli cells produce ESTROGENS.
Also Known As:
Androblastomas; Arrhenoblastomas; Sertoli Leydig Cell Tumor; Tumor, Sertoli-Leydig Cell; Androblastoma Show All >>
Key Drugs and Agents for Sertoli-Leydig Cell Tumor
Efficacy Chart >>
Drugs and Important Biological Agents (IBA) related to treatments:
-
Testosterone (Sustanon)
:
3 studies in 12 results
:
FDA 12
Generic
-
Androstenedione (4 Androstene 3,17 dione)
:
1 study in 4 results
: IBA
-
Adrenocorticotropic Hormone (ACTH)
:
1 study in 4 results
:
FDA 6
-
Inhibins (Inhibin)
:
1 study in 3 results
: IBA
-
Dexamethasone (Maxidex)
:
1 study in 3 results
:
FDA 74
Generic
-
RNA (Ribonucleic Acid)
:
1 study in 2 results
: IBA
-
Pregnenolone
:
1 study in 2 results
: IBA
-
Chorionic Gonadotropin (Human Chorionic Gonadotropin)
:
1 study in 2 results
:
FDA 12
Generic
-
harpin (messenger)
:
1 study in 2 results
: IBA
-
Hydroxysteroid Dehydrogenases
:
1 study in 1 result
: IBA
Show All >>
Diseases Related to Sertoli-Leydig Cell Tumor
-
Sertoli-Leydig Cell Tumor
-
Neoplasms (Cancer)
-
Granulosa Cell Tumor
-
Virilism (Virilization)
-
Ovarian Neoplasms (Ovarian Cancer)
Show All >>
Key Therapies for Sertoli-Leydig Cell Tumor
Efficacy Chart >>
-
Ovariectomy (Oophorectomy)
:
5 results
-
Laparotomy
:
5 results
-
Drug Therapy (Chemotherapy)
:
2 results
-
Adjuvant Chemotherapy
:
1 result
-
Adrenalectomy
:
1 result
CureHunter Inc. provides medical information and specifically does NOT provide medical advice.
© Copyright 2003-2008 CureHunter Inc., MeSH copyright NLM, Journal Articles copyright original owners.